Libin Ren

544 total citations · 1 hit paper
6 papers, 294 citations indexed

About

Libin Ren is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Libin Ren has authored 6 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Libin Ren's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Cardiovascular Function and Risk Factors (2 papers). Libin Ren is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Cardiovascular Function and Risk Factors (2 papers). Libin Ren collaborates with scholars based in China. Libin Ren's co-authors include Hongliang Cong, Yuecheng Hu, Le Wang, Ao Wei, Hua Yang, Wei Qi, Jingxia Zhang, Jinghan Xu, Zhang Yingyi and Rui Zhang and has published in prestigious journals such as Cardiovascular Diabetology, Frontiers in Cardiovascular Medicine and Angiology.

In The Last Decade

Libin Ren

6 papers receiving 291 citations

Hit Papers

Triglyceride-glucose index predicts adverse cardiovascula... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libin Ren China 5 188 166 90 58 46 6 294
Yuecheng Hu China 6 213 1.1× 166 1.0× 89 1.0× 68 1.2× 64 1.4× 26 342
Zhenguo Wu China 9 165 0.9× 170 1.0× 123 1.4× 36 0.6× 33 0.7× 16 306
Side Gao China 10 195 1.0× 148 0.9× 59 0.7× 64 1.1× 88 1.9× 23 325
Qirui Song China 8 132 0.7× 116 0.7× 89 1.0× 38 0.7× 40 0.9× 15 266
Geng Liu China 7 119 0.6× 137 0.8× 76 0.8× 36 0.6× 49 1.1× 16 243
Ying-Kai Xu China 7 231 1.2× 188 1.1× 95 1.1× 73 1.3× 96 2.1× 14 380
Huiliang Cui China 7 132 0.7× 149 0.9× 96 1.1× 25 0.4× 30 0.7× 13 233
Chun‐Yip Yeung Hong Kong 9 172 0.9× 115 0.7× 66 0.7× 25 0.4× 29 0.6× 11 332
Najmusaqib Khan Niazi Pakistan 3 101 0.5× 163 1.0× 111 1.2× 18 0.3× 38 0.8× 7 276
Marcel T. Ferreira Brazil 9 258 1.4× 135 0.8× 47 0.5× 33 0.6× 52 1.1× 10 367

Countries citing papers authored by Libin Ren

Since Specialization
Citations

This map shows the geographic impact of Libin Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libin Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libin Ren more than expected).

Fields of papers citing papers by Libin Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libin Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libin Ren. The network helps show where Libin Ren may publish in the future.

Co-authorship network of co-authors of Libin Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Libin Ren. A scholar is included among the top collaborators of Libin Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libin Ren. Libin Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Wang, Le, Jingxia Zhang, Ximing Li, et al.. (2022). Prognostic performance of multiple biomarkers in patients with acute coronary syndrome without standard cardiovascular risk factors. Frontiers in Cardiovascular Medicine. 9. 916085–916085. 4 indexed citations
2.
Zhang, Shihan, Hua Yang, Libin Ren, et al.. (2022). Triglyceride Glucose Index for Predicting Major Adverse Cardiovascular Events in Chinese Patients with Hypertension. Angiology. 74(3). 259–267. 5 indexed citations
3.
Cong, Hongliang, Jingxia Zhang, Yuecheng Hu, et al.. (2021). Prognostic Significance of Preprocedural N-Terminal Pro-B-Type Natriuretic Peptide Assessment in Diabetic Patients With Multivessel Coronary Disease Undergoing Revascularization. Frontiers in Cardiovascular Medicine. 8. 721260–721260. 4 indexed citations
4.
Zhang, Yingyi, Libin Ren, Min Ren, et al.. (2021). Correlation Between the Triglyceride–Glucose Index and High Risk of Cardiovascular Disease: A Cohort Study of 102,061 Subjects from Tianjin, China. Risk Management and Healthcare Policy. Volume 14. 2803–2810. 8 indexed citations
5.
Wang, Le, Hongliang Cong, Jingxia Zhang, et al.. (2021). Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins. Frontiers in Cardiovascular Medicine. 8. 718604–718604. 13 indexed citations
6.
Wang, Le, Hongliang Cong, Jingxia Zhang, et al.. (2020). Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovascular Diabetology. 19(1). 80–80. 260 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026